Clinical trial
Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent…
NCT00019916 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019916 |
|---|---|
| Title | Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer |
| Official title | Vaccine Therapy With Tumor Specific p53 Peptides in Adult Patients With Adenocarcinoma of the Breast or Ovary |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Ovarian Cancer |
| Intervention type | Biological, Procedure |
| Interventions | aldesleukin, p53 peptide vaccine, in vitro-treated peripheral blood stem cell transplantation |
| Start date | Jun 1, 2000 |
| Completion | Jul 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: